Sadhna J Joglekar
Overview
Explore the profile of Sadhna J Joglekar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
24
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahay R, Gangwani D, Singh M, Gupta S, Kale N, Srivastava M, et al.
Diabetes Obes Metab
. 2025 Feb;
27(4):2193-2205.
PMID: 39950245
Aim: To evaluate the efficacy and safety of a triple fixed-dose combination (FDC) therapy of dapagliflozin + glimepiride + metformin hydrochloride extended-release (DAPA + GLIM + MET ER) tablets in...
2.
Sahay R, Giri R, Shembalkar J, Gupta S, Mohan B, Kurmi P, et al.
Adv Ther
. 2023 May;
40(7):3227-3246.
PMID: 37258803
Introduction: This study compared efficacy and safety of triple drug fixed-dose combination (FDC) of dapagliflozin (DAPA) + sitagliptin (SITA) + metformin (MET) extended release (ER) with SITA + MET sustained...
3.
Yeole A, Sree Ranga Lakshmi G, Selvakumar C, Goni V, Nawal C, Valya B, et al.
Pain Ther
. 2022 Oct;
11(4):1451-1469.
PMID: 36224489
Introduction: Currently available treatments for chronic lower back pain (CLBP) do not adequately address both nociceptive and neuropathic components of pain. We evaluated efficacy and safety of fixed-dose combination (FDC)...
4.
Kamerkar D, John M, Desai S, Dsilva L, Joglekar S
Indian J Crit Care Med
. 2016 Apr;
20(3):150-8.
PMID: 27076726
Background And Aim: There is lack of substantial Indian data on venous thromboembolism (VTE). The aim of this study was to provide real-world information on patient characteristics, management strategies, clinical...